Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 20, 2026
TickeronGET DAILY SIGNALS
Why Is Marex Group Limited (MRX) Stock Down -7.75% Today?

Why Is Marex Group Limited (MRX) Stock Down -7.75% Today?

Key Takeaways

  • Sharp decline: MRX fell $4.76, or 7.75%, to $56.66, its fourth consecutive losing session and the steepest one-day drop in more than 60 trading sessions.
  • Primary catalyst: No fresh company announcement, filing, or analyst action explains Friday's selling; the move extends a post-earnings de-rating that began after record third-quarter results on Nov. 5 failed to hold gains.
  • Secondary drivers: A technical breakdown below intermediate trend lines near $66.60 and $67.80, deeply negative momentum readings, and heavier-than-normal turnover.
  • Broader context: The stock is down roughly 23% from its Nov. 11 close of $73.93 and about 28% from its 52-week high of $79.11, yet remains up roughly 49% year to date.
  • News Significance Score: 34/100 — stale post-earnings news alongside a decline roughly three times the stock's normal daily swing.
  • What traders are watching: Whether the $55–$56 area holds, fourth-quarter exchange volumes, and management commentary ahead of full-year results expected in early March.
  • Dive deeper into Price Targets, Earnings, and Forecast pages for detailed analysis and projections.
  • Explore Trending AI Robots to see which automated strategies are leading in the current market environment.

Opening Summary

Marex Group Limited (MRX) is a London-based diversified financial services platform that provides clearing, agency and execution, market making, and hedging solutions to clients across commodity and financial markets, with a focus on institutional counterparties. Its shares were trading at $56.66 at 10:38 a.m. ET on Friday, down $4.76, or 7.75%, from Thursday's close of $61.42. The direction was decisively lower. The stock has now fallen in four straight sessions, sliding from $73.93 on Nov. 11, and no new company disclosure, filing, or analyst revision on Friday accounts for the move. The selling is instead a continuation of the de-rating that began when record third-quarter results on Nov. 5 were met with a 7.65% decline.

The Post-Earnings De-Rating Behind the Slide

The fundamental backdrop is not the problem. Marex's third-quarter report on Nov. 5 showed revenue up 53% year over year to $743.2 million and adjusted profit before tax up 75% to $176.1 million, with adjusted earnings per share of $1.67 ahead of the $1.54 consensus and revenue comfortably above the $681.5 million expected. Adjusted return on equity held at 36%.

What unsettled investors was the shape of the growth and what comes next. Adjusted expenses rose 44%, front-office compensation climbed 49%, and higher funding costs trimmed interest income. Management's guidance for 10% to 20% adjusted profit before tax growth in 2027 sits well below the pace delivered through the first nine months of 2026, when profit before tax rose 63%. For a stock that entered November up more than 80% over twelve months, that reset in the growth trajectory was enough to reprice the multiple, and the initial post-earnings decline set the tone for the month.

No verified news or fundamental catalyst found

No verified news or fundamental catalyst was identified for Friday's session. The company's most recent regulatory filing remains the Nov. 5 results release, and no press release, rating change, or corporate development was published ahead of the open. The move is therefore best understood as a technical and positioning event. The stock has broken below its intermediate trend lines, including its weekly and monthly averages near $66.60 and $67.80, leaving it several percent below every major reference level. Momentum measures have deteriorated in tandem, with MACD sitting below zero and short-term oscillators sliding from overbought territory into oversold readings — a pattern consistent with persistent trend-following and momentum-driven selling rather than a single discretionary decision.

Liquidity amplifies that dynamic. With a float of about 66 million shares and average turnover near 360,000 shares a session, modest institutional outflows translate into outsized price gaps. The $0.16 quarterly dividend that went ex on Nov. 16 is a mechanical adjustment far too small to explain a decline of this size, and short interest of roughly 3% of shares outstanding is too low to suggest a squeeze narrative in either direction.

Market Context and Trading Activity

Volume has been elevated. Thursday's turnover of roughly 771,000 shares was more than double the 90-session average of about 360,000, and Nov. 18 also traded well above normal — the signature of distribution rather than drift. The decline has outpaced the broader tape in recent sessions, pointing to stock-specific positioning after a long run rather than a sector-wide shock. The stock is now about 28% below its 52-week high of $79.11 but still roughly 49% above where it started the year, leaving a large embedded gain that recent buyers have been willing to realize. The immediate technical question is support: the $60 zone that held through late October and early November has given way, shifting attention to the mid-$50s.

News Significance Score

The score runs from 0, meaning no meaningful news and a move that is normal for the stock, to 100, meaning transformative news and an extreme, rare price move. MRX scores 34 out of 100. The verified news is weak relative to the calendar: the last material disclosure was the Nov. 5 third-quarter report, a record quarter that was already two weeks old and already reflected in the price. The price behavior is more noteworthy. Friday's 7.75% decline is roughly 3.1 times the stock's 2.5% average absolute daily move over the past 90 sessions and the largest single-session drop in more than 60 sessions. A stale catalyst paired with a moderately unusual move produces a below-midpoint score.

What Comes Next for MRX

Attention turns to the fourth-quarter and full-year 2026 report, expected in early March. Management has guided to 10% to 20% adjusted profit before tax growth in 2027, a framework that includes the full-year contribution from 2026 acquisitions and the pending Bright Point purchase, which is expected to close in early 2027 and strengthen clearing access in Asia. Four further transactions have agreed commercial terms. The key swing factors are exchange volumes, which grew about 20% year over year in the third quarter versus a historical trend of 8% to 10%, and volatility across metals and energy, where elevated activity has been supporting agency and market-making revenue. Average clearing client balances of $18.7 billion, up 41%, remain the earnings engine and are sensitive to the path of interest rates. Risks include leverage on the balance sheet, integration execution across a heavy acquisition cadence, credit-loss provisions following January's single-client default, and further multiple compression if growth normalizes faster than expected. The consensus rating remains Buy.

Trending AI Robots

Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions appear in the curated Trending AI Robots section. Bots differ widely by strategy, timeframe, performance metrics, and the symbols they trade, so the leaders rotate as volatility and market regimes shift. Reviewing the live leaderboard is a practical way to see which approaches are working right now and how they might complement your own research.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MRX

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


MRX in downward trend: 10-day moving average moved below 50-day moving average on October 19, 2026

The 10-day moving average for MRX crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 3 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MRX as a result. In 34 of 49 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.

The Moving Average Convergence Divergence Histogram (MACD) for MRX turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 24 similar instances when the indicator turned negative. In 15 of the 24 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.

MRX moved below its 50-day moving average on November 13, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.

MRX broke above its upper Bollinger Band on November 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MRX entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +8.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRX advanced for three days, in 152 of 176 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. MRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.545) is normal, around the industry mean (3.143). P/E Ratio (11.570) is within average values for comparable stocks, (6.733). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.010) settles around the average of (8.976) among similar stocks. P/S Ratio (1.260) is also within normal values, averaging (17.075).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 11.61B. The market cap for tickers in the group ranges from 590 to 284.96B. MS holds the highest valuation in this group at 284.96B. The lowest valued company is FSSLD at 590.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was 6%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -30%. NCPL experienced the highest price growth at 90%, while SOS experienced the biggest fall at -95%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was 42%. For the same stocks of the Industry, the average monthly volume growth was 20% and the average quarterly volume growth was -39%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 67
P/E Growth Rating: 65
Price Growth Rating: 71
SMR Rating: 74
Profit Risk Rating: 88
Seasonality Score: -2 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry InvestmentBanksBrokers

Industry
N/A
Address
155 Bishopsgate
Phone
+44 2076556000
Employees
3282
Web
https://www.marex.com
Interact to see
Advertisement
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
ROM is an established, leveraged exchange-traded fund (ETF) that targets twice (2x) the daily return of the S&P Technology Select Sector Index, while XXX is a recently launched blended ETF pairing large-cap U.S. equities with XRP exposure. ROM benefits from deep liquidity and roughly $1.1 billion in AUM (assets under management); XXX remains far smaller, with assets measured in the hundreds of thousands of dollars.
NVIDIA (NVDA) has declined roughly 32.6% over the last 30 days, falling from $216.47 on October 20 to around $146 in mid-November trading. The selloff was triggered by the surprise resignation of founder and CEO Jensen Huang, along with governance, regulatory, and China-related concerns.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Why Is Marex Group Limited (MRX) Stock Down -7.75% Today?